| 期 |
标题 |
文件 |
| 卷 31, 编号 14 (2024) |
Impact of Statin or Fibrate Therapy on Homocysteine Concentrations: A Systematic Review and Meta-analysis |
(Eng)
|
|
Akbari A., Islampanah M., Arhaminiya H., Alvandi Fard M., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 16 (2024) |
Development in the Inhibition of Dengue Proteases as Drug Targets |
(Eng)
|
|
Akram M., Hameed S., Hassan A., Khan K.
|
| 卷 31, 编号 16 (2024) |
Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next? |
(Eng)
|
|
González J., Salas-Sarduy E., Alvarez L., Valiente P., Arni R., Pascutti P.
|
| 卷 31, 编号 16 (2024) |
Targeting SmCB1: Perspectives and Insights to Design Antischistosomal Drugs |
(Eng)
|
|
dos Santos Nascimento I., Albino S., da Silva Menezes K., de Azevedo Teotônio Cavalcanti M., de Oliveira M., Mali S., de Moura R.
|
| 卷 31, 编号 16 (2024) |
Discovery of Novel Inhibitors of Cruzain Cysteine Protease of Trypanosoma cruzi |
(Eng)
|
|
Prates J., Lopes J., Chin C., Ferreira E., dos Santos J., Scarim C.
|
| 卷 31, 编号 17 (2024) |
Non-oxidative vs Oxidative Forms of Modified Low-density Lipoprotein: What is More Important in Atherogenesis? |
(Eng)
|
|
Orekhov A., Khotina V., Sukhorukov V., Sobenin I.
|
| 卷 31, 编号 17 (2024) |
Chalcone Derivatives as Antibacterial Agents: An Updated Overview |
(Eng)
|
|
de Oliveira A., Cenci A., Gonçalves L., Thedy M., Justino A., Braga A., Meier L.
|
| 卷 31, 编号 17 (2024) |
Recent Advances on the Antimicrobial Activities of Schiff Bases and their Metal Complexes: An Updated Overview |
(Eng)
|
|
Jorge J., Del Pino Santos K., Timóteo F., Piva Vasconcelos R., Ignacio Ayala Cáceres O., Juliane Arantes Granja I., de Souza D., Allievi Frizon T., Di Vaccari Botteselle G., Luiz Braga A., Saba S., Rashid H., Rafique J.
|
| 卷 31, 编号 17 (2024) |
Environmental Risk Factors in Autism Spectrum Disorder: A Narrative Review |
(Eng)
|
|
Yenkoyan K., Mkhitaryan M., Bjørklund G.
|
| 卷 31, 编号 17 (2024) |
Exploring Scoring Function Space: Developing Computational Models for Drug Discovery |
(Eng)
|
|
Bitencourt-Ferreira G., Villarreal M., Quiroga R., Biziukova N., Poroikov V., Tarasova O., de Azevedo Junior W.
|
| 卷 31, 编号 17 (2024) |
A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma |
(Eng)
|
|
Wang T., Chen P., Li T., Li J., Zhao D., Meng F., Zhao Y., Zheng Z., Liu X.
|
| 卷 31, 编号 16 (2024) |
Drug Discovery Efforts to Identify Novel Treatments for Neglected Tropical Diseases - Cysteine Protease Inhibitors |
(Eng)
|
|
Giroud M., Kuhn B., Haap W.
|
| 卷 31, 编号 16 (2024) |
Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis |
(Eng)
|
|
Saha A., Pushpa ., Moitra S., Basak D., Brahma S., Mondal D., Molla S., Samadder A., Nandi S.
|
| 卷 31, 编号 16 (2024) |
Targeting Cysteine and Serine Proteases to Discover New Drugs Against Neglected Tropical Diseases |
(Eng)
|
|
dos Santos Nascimento I., de Moura R.
|
| 卷 31, 编号 14 (2024) |
High-sensitivity Troponin (hs-Tn) for Cardiovascular Risk Prognostication: A Systematic Review and Meta-analysis |
(Eng)
|
|
Sagris M., Antonopoulos A., Angelopoulos A., Papanikolaou P., Simantiris S., Vamvakaris C., Koumpoura A., Farmaki M., Antoniades C., Tsioufis C., Tousoulis D.
|
| 卷 31, 编号 15 (2024) |
State-of-the-art Review on the Antiparasitic Activity of Benzimidazolebased Derivatives: Facing Malaria, Leishmaniasis, and Trypanosomiasis |
(Eng)
|
|
Francesconi V., Rizzo M., Schenone S., Carbone A., Tonelli M.
|
| 卷 31, 编号 15 (2024) |
Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma |
(Eng)
|
|
Trojan A., Lone Y., Briceno I., Trojan J.
|
| 卷 31, 编号 15 (2024) |
Revisiting the Role of B-RAF Kinase as a Therapeutic Target in Melanoma |
(Eng)
|
|
Kozyra P., Pitucha M.
|
| 卷 31, 编号 15 (2024) |
Targeting NLRP3 Inflammasome: Structure, Function, and Inhibitors |
(Eng)
|
|
Lou S., Wu M., Cui S.
|
| 卷 31, 编号 15 (2024) |
Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus |
(Eng)
|
|
Kamal S., Shahzad A., Rehman K., Tariq K., Akash M., Imran M., Assiri M.
|
| 卷 31, 编号 15 (2024) |
Serine Protease 27, a Prognostic Biomarker in Pan-cancer and Associated with the Aggressive Progression of Breast Cancer |
(Eng)
|
|
Xu Y., Shen Y., Bhandari A., Hirachan S., Wang O., Xia E.
|
| 卷 31, 编号 15 (2024) |
Synthesis and Selective Anticancer Activity Evaluation of 2-phenylacrylonitrile Derivatives as Tubulin Inhibitors |
(Eng)
|
|
Jin Y., Xin Y., Li Y., Chen X., Man D., Tian Y.
|
| 卷 31, 编号 15 (2024) |
Resveratrol Inhibits Hepatocellular Carcinoma Progression through Regulating Exosome Secretion |
(Eng)
|
|
Tong K., Wang P., Li Y., Tong Y., li X., Yan S., Hu P.
|
| 卷 31, 编号 15 (2024) |
Ginsenoside Rg1 Suppresses Ferroptosis of Renal Tubular Epithelial Cells in Sepsis-induced Acute Kidney Injury via the FSP1-CoQ10- NAD(P)H Pathway |
(Eng)
|
|
Guo J., Chen L., Ma M.
|
| 卷 31, 编号 17 (2024) |
LIMD2 is the Signature of Cell Aging-immune/Inflammation in Acute Myocardial Infarction |
(Eng)
|
|
Tao P., Chen X., Xu L., Chen J., Nie Q., Xu M., Feng J.
|
| 卷 31, 编号 17 (2024) |
Comprehensive scRNA-seq Analysis and Identification of CD8_+T Cell Related Gene Markers for Predicting Prognosis and Drug Resistance of Hepatocellular Carcinoma |
(Eng)
|
|
Cao L., Liu M., Ma X., Rong P., Zhang J., Wang W.
|
| 卷 31, 编号 19 (2024) |
Biology of Tenascin C and its Role in Physiology and Pathology |
(Eng)
|
|
Abedsaeidi M., Hojjati F., Tavassoli A., Sahebkar A.
|
| 卷 31, 编号 19 (2024) |
A Review on the Efficacy and Safety of Intrathecal Administration of Novel Medications for Leptomeningeal Metastases in Solid Cancers |
(Eng)
|
|
Jafari F., Nodeh M., Hosseinjani H., Baharara H., Azad S., Arasteh O., Johnston T., Sahebkar A.
|
| 卷 31, 编号 19 (2024) |
Crosstalk between Oxidative Stress and Inflammation Induced by Ionizing Radiation in Healthy and Cancerous Cells |
(Eng)
|
|
Mohammadgholi M., Hosseinimehr S.
|
| 卷 31, 编号 19 (2024) |
An Update on Parkinsons Disease and its Neurodegenerative Counterparts |
(Eng)
|
|
Adam H., Gopinath S., Arshad M., Adam T., Subramaniam S., Hashim U.
|
| 卷 31, 编号 19 (2024) |
Emodin Alcohols: Design, Synthesis, Biological Evaluation and Multitargeting Studies with DNA, RNA, and HSA |
(Eng)
|
|
Wang H., Zhang H.
|
| 卷 31, 编号 19 (2024) |
Potential Role of Bone Metabolism Markers in Kidney Transplant Recipients |
(Eng)
|
|
Vigil F., Castro P., Hasparyk U., Bartolomei V., Silva A.
|
| 卷 31, 编号 19 (2024) |
Modulation of the HIF-1α-NCOA4-FTH1 Signaling Axis Regulating Ferroptosis-induced Hepatic Stellate Cell Senescence to Explore the Anti-hepatic Fibrosis Mechanism of Curcumol |
(Eng)
|
|
Zheng Y., Wang L., Wang J., Zhao T., Wang J.
|
| 卷 31, 编号 2 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Benbrook D.
|
| 卷 31, 编号 2 (2024) |
The Importance of Nanocarriers Intra- and Extracellular Degradation: What we Know and Should Know About it? |
(Eng)
|
|
Parodi A., Voronina M., Zamyatnin A.
|
| 卷 31, 编号 2 (2024) |
Estrogen Receptor and the Gender Bias in Raynauds Phenomenon |
(Eng)
|
|
Fardoun M., Kobeissy F., Eid A.
|
| 卷 31, 编号 19 (2024) |
Hybrids Diazine: Recent Advancements in Modern Antimicrobial Therapy |
(Eng)
|
|
Mangalagiu V., Danac R., Diaconu D., Zbancioc G., Mangalagiu I.
|
| 卷 31, 编号 19 (2024) |
The Development of Non-natural Type Nucleoside to Stabilize Triplex DNA Formation against CG and TA Inversion Site |
(Eng)
|
|
Wang L., Ling Y., Tian Y., Wang X., Sasaki S., Taniguchi Y.
|
| 卷 31, 编号 19 (2024) |
Multimodality Cardiac Imaging Biomarkers and Atrial Fibrillation Substrate: Are they Worthwhile? |
(Eng)
|
|
Androulakis E., Ahsan S., Papageorgiou N.
|
| 卷 31, 编号 17 (2024) |
High-Resolution Profiling of Head and Neck Squamous Cells Carcinoma Identifies Specific Biomarkers and Expression Subtypes of Clinically Relevant Vulnerabilities |
(Eng)
|
|
Zhu Y., Peng B., Luo X., Sun W., Liu D., Li N., Qiu P., Long G.
|
| 卷 31, 编号 17 (2024) |
Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction |
(Eng)
|
|
Li X., Lei J., Shi Y., Peng Z., Gong M., Shu X.
|
| 卷 31, 编号 17 (2024) |
Systematic Analysis of Tumor Stem Cell-related Gene Characteristics to Predict the PD-L1 Immunotherapy and Prognosis of Gastric Cancer |
(Eng)
|
|
Wang C., Chen Y., Zhou R., Yang Y., Fang Y.
|
| 卷 31, 编号 18 (2024) |
The Importance of a Novel Syndemic Approach for Cardiometabolic Diseases |
(Eng)
|
|
Rizzo M.
|
| 卷 31, 编号 18 (2024) |
A Comprehensive Review on the State of the Art of Breast Cancers in Italy |
(Eng)
|
|
Iacopetta D., Ceramella J., Catalano A., Rosano C., Mariconda A., Giuzio F., Bonofiglio D., Saturnino C., Longo P., Sinicropi M.
|
| 卷 31, 编号 18 (2024) |
Antiviral Compounds to Address Influenza Pandemics: An Update from 2016-2022 |
(Eng)
|
|
Romeo R., Legnani L., Chiacchio M., Giofrè S., Iannazzo D.
|
| 卷 31, 编号 18 (2024) |
miR-26a is a Key Therapeutic Target with Enormous Potential in the Diagnosis and Prognosis of Human Disease |
(Eng)
|
|
Guan W., Chen Y., Fan Y.
|
| 卷 31, 编号 18 (2024) |
Recent Advances in Research on Active Compounds Against Hepatic Fibrosis |
(Eng)
|
|
Liu C., Li S., Zhang C., Jin C.
|
| 卷 31, 编号 18 (2024) |
The Therapeutic Effect of Natural Compounds on Osteoporosis through Ferroptosis |
(Eng)
|
|
Zhang Y., Qu Z., Zhao Y., Zhang B., Gong Y., Wang X., Gao X., Wang D., Yan L.
|
| 卷 31, 编号 18 (2024) |
Efficacy of Chemoimmunotherapy versus Chemotherapy for Gastric Cancer: A Meta-Analysis of Survival Outcomes |
(Eng)
|
|
Xie J., Chen L., Liu Q., Li X., Lei X.
|
| 卷 31, 编号 2 (2024) |
Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitors in the Diabetic Milieu |
(Eng)
|
|
Yaribeygi H., Maleki M., Sathyapalan T., Rizzo M., Sahebkar A.
|
| 卷 31, 编号 1 (2024) |
Preface |
(Eng)
|
|
Atta-ur-Rahman .
|
| 卷 31, 编号 11 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Iqbal J.
|
| 卷 31, 编号 11 (2024) |
Sleep, Dietary Melatonin Supplementation, and COVID-19 |
(Eng)
|
|
Gasmi A., Semenova Y., Noor S., Benahmed A., Bjørklund G.
|
| 卷 31, 编号 11 (2024) |
Melatonin as a Promising Agent for Cancer Treatment: Insights into its Effects on the Wnt/beta-catenin Signaling Pathway |
(Eng)
|
|
Davoodvandi A., Asemi R., Sharifi M., Reiter R., Matini S., Mirhashemi S., Asemi Z.
|
| 卷 31, 编号 11 (2024) |
Peptide Amphiphiles for Pharmaceutical Applications |
(Eng)
|
|
Fuertes-Llanos M., Gómara M., Haro I., Sánchez-López E.
|
| 卷 31, 编号 11 (2024) |
The Effect of Statins on the Differentiation and Function of Central Nervous System Cells |
(Eng)
|
|
Chamani S., Mobasheri L., Zerehpoosh S., Naghizadeh A., McCloskey A., Rizzo M., Jamialahmadi T., Sahebkar A.
|
| 卷 31, 编号 11 (2024) |
Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists |
(Eng)
|
|
Ghafir El Idrissi I., Podlewska S., Abate C., Bojarski A., Lacivita E., Leopoldo M.
|
| 卷 31, 编号 11 (2024) |
New Insights into the Long Non-coding RNAs Dependent Modulation of Heart Failure and Cardiac Hypertrophy: From Molecular Function to Diagnosis and Treatment |
(Eng)
|
|
Rezaee M., Masihipour N., Milasi Y., Dehmordi R., Reiner ., Asadi S., Mohammadi F., Khalilzadeh P., Rostami M., Asemi Z., Mafi A.
|
| 卷 31, 编号 12 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Cichero E.
|
| 卷 31, 编号 12 (2024) |
Perspectives on Iron Deficiency as a Cause of Human Disease in Global Public Health |
(Eng)
|
|
Bjørklund G., Semenova Y., Hangan T., Pen J., Aaseth J., Peana M.
|
| 卷 31, 编号 12 (2024) |
The Structure-property Relationships of Clinically Approved Protease Inhibitors |
(Eng)
|
|
Choi K.
|
| 卷 31, 编号 10 (2024) |
Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses |
(Eng)
|
|
De S.
|
| 卷 31, 编号 10 (2024) |
Simple Synthesis of [18F] AV-45 and its Clinical Application in the Diagnosis of Alzheimer's Disease |
(Eng)
|
|
Zhang Q., Yilihamu N., Li Y., Li X., Qin Y.
|
| 卷 31, 编号 10 (2024) |
Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity |
(Eng)
|
|
Shayan S., Nasrollahi E., Bahramvand Y., Zarei M., Atarodi A., Farsi Y., Tavakolizadeh M., Shirvaliloo M., Abbasifard M., Jamialahmadi T., Banach M., Sahebkar A.
|
| 卷 31, 编号 1 (2024) |
Long COVID-19 Syndrome and Sudden Cardiac Death: The Phantom Menace |
(Eng)
|
|
Spartalis M., Zweiker D., Spartalis E., Iliopoulos D., Siasos G.
|
| 卷 31, 编号 1 (2024) |
Research Progress on Antiviral Activity of Heparin |
(Eng)
|
|
Wang Y., Zhang Y., Wang P., Jing T., Hu Y., Chen X.
|
| 卷 31, 编号 1 (2024) |
Anti-obesity Properties of Phytochemicals: Highlighting their Molecular Mechanisms against Obesity |
(Eng)
|
|
Poulios E., Koukounari S., Psara E., Vasios G., Sakarikou C., Giaginis C.
|
| 卷 31, 编号 1 (2024) |
Naturally Occurring Xanthones; Biological Activities, Chemical Profiles and In Silico Drug Discovery |
(Eng)
|
|
El-Seedi H., Ibrahim H., Yosri N., Ibrahim M., Hegazy M., Setzer W., Guo Z., Zou X., Refaey M., Salem S., Musharraf S., Saeed A., Salem S., Xu B., Zhao C., Khalifa S.
|
| 卷 31, 编号 1 (2024) |
PBPK Modeling as an Alternative Method of Interspecies Extrapolation that Reduces the Use of Animals: A Systematic Review |
(Eng)
|
|
Lancheros Porras K., Alves I., Novoa D.
|
| 卷 31, 编号 10 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Heymann D.
|
| 卷 31, 编号 10 (2024) |
Oxocarbon Acids and their Derivatives in Biological and Medicinal Chemistry |
(Eng)
|
|
Ratto A., Honek J.
|
| 卷 31, 编号 10 (2024) |
Berberine: Pharmacological Features in Health, Disease and Aging |
(Eng)
|
|
Gasmi A., Asghar F., Zafar S., Oliinyk P., Khavrona O., Lysiuk R., Peana M., Piscopo S., Antonyak H., Pen J., Lozynska I., Noor S., Lenchyk L., Muhammad A., Vladimirova I., Dub N., Antoniv O., Tsal O., Upyr T., Bjørklund G.
|
| 卷 31, 编号 10 (2024) |
Cardiospecific Troponins as Laboratory Biomarkers of Myocardial Cell Injury in Hypertension: A Mini-Review |
(Eng)
|
|
Chaulin A.
|
| 卷 31, 编号 10 (2024) |
LncRNA-mediated Modulation of Endothelial Cells: Novel Progress in the Pathogenesis of Coronary Atherosclerotic Disease |
(Eng)
|
|
Ouyang S., Zhou Z., Liu H., Ren Z., Liu H., Deng N., Tian K., Zhou K., Xie H., Jiang Z.
|
| 卷 31, 编号 12 (2024) |
A Review on Graphene Analytical Sensors for Biomarker-based Detection of Cancer |
(Eng)
|
|
Patil S., Patil N., Mahajan M., Madhavi V., Gopinath S., Ramanathan S., More M., Patil K.
|
| 卷 31, 编号 12 (2024) |
Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies |
(Eng)
|
|
Yenkoyan K., Ounanian Z., Mirumyan M., Hayrapetyan L., Zakaryan N., Sahakyan R., Bjørklund G.
|
| 卷 31, 编号 13 (2024) |
The Effect of Statin Therapy on Serum Uric Acid Levels: A Systematic Review and Meta-analysis |
(Eng)
|
|
Akbari A., Razmi M., Rafiee M., Watts G., Sahebkar A.
|
| 卷 31, 编号 13 (2024) |
Inflammatory Response Modulation by Low-Dose Anti-inflammatory Drugs Treatment in an In Vitro Osteoarthritis Cellular Model |
(Eng)
|
|
Iuliano M., Santilli V., Mineo A., Paoloni M., Rosa P., Mangino G., Romeo G.
|
| 卷 31, 编号 13 (2024) |
Identification of a Novel Diagnosis Model based on 5 Hub Genes for Chronic Thromboembolic Pulmonary Hypertension |
(Eng)
|
|
Zhang F., Huang X., Lin J., Yu R., Lin S., Shen G., Chen W.
|
| 卷 31, 编号 13 (2024) |
Metabolome Profiling of Malignant Ascites Identifies Candidate Metabolic Biomarkers of Hepatocellular Carcinoma |
(Eng)
|
|
Wang W., Wu Y., Zhang Q., Cui P.
|
| 卷 31, 编号 14 (2024) |
Unlocking the Benefits of Fasting: A Review of its Impact on Various Biological Systems and Human Health |
(Eng)
|
|
Mackieh R., Al-Bakkar N., Kfoury M., Okdeh N., Pietra H., Roufayel R., Legros C., Fajloun Z., Sabatier J.
|
| 卷 31, 编号 14 (2024) |
Coenzyme Q10 for Enhancing Physical Activity and Extending the Human Life Cycle |
(Eng)
|
|
Bjørklund G., Semenova Y., Gasmi A., Ruwan Indika N., Hrynovets I., Lysiuk R., Lenchyk L., Uryr T., Yeromina H., Peana M.
|
| 卷 31, 编号 14 (2024) |
Drugs to Treat Neuroinflammation in Neurodegenerative Disorders |
(Eng)
|
|
Wang Y., Kung W., Chung Y., Kumar S.
|
| 卷 31, 编号 14 (2024) |
MicroRNA-mediated Regulation of LDL Receptor: Biological and Pharmacological Implications |
(Eng)
|
|
Keshavarz R., Reiner ., Zengin G., Eid A., Sahebkar A.
|
| 卷 31, 编号 14 (2024) |
Chemical Strategies towards the Development of Effective Anticancer Peptides |
(Eng)
|
|
Li C., Jin K.
|
| 卷 31, 编号 14 (2024) |
The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer Therapy |
(Eng)
|
|
Cui Y., Zhang J., Zhang G.
|
| 卷 31, 编号 13 (2024) |
Role of LncRNA MIAT in Diabetic Complications |
(Eng)
|
|
Wang L., Wang H., Luo Y., Wu W., Gui Y., Zhao J., Xiong R., Li X., Yuan D., Yuan C.
|
| 卷 31, 编号 13 (2024) |
Multiple Natural Polymers in Drug and Gene Delivery Systems |
(Eng)
|
|
Jiang Z., Song Z., Cao C., Yan M., Liu Z., Cheng X., Wang H., Wang Q., Liu H., Chen S.
|
| 卷 31, 编号 13 (2024) |
Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine |
(Eng)
|
|
Dhanjal D., Singh R., Sharma V., Nepovimova E., Adam V., Kuca K., Chopra C.
|
| 卷 31, 编号 12 (2024) |
Spinal Muscular Atrophy Treatment: The MTOR Regulatory Intervention |
(Eng)
|
|
Lashgari N., Roudsari N., Shayan M., Eshraghi S., Momtaz S., Jamialahmadi T., Abdolghaffari A., Sahebkar A.
|
| 卷 31, 编号 12 (2024) |
Single-cell Sequencing Data Reveals Aggressive CD68-type Macrophages and Prognostic Models in Bladder Cancer |
(Eng)
|
|
Mao C., Xu N.
|
| 卷 31, 编号 12 (2024) |
Construction of RNA Methylation Modification-immune-related lncRNA Molecular Subtypes and Prognostic Scoring System in Lung Adenocarcinoma |
(Eng)
|
|
Wang J., Shu J.
|
| 卷 31, 编号 12 (2024) |
Heterogeneity of Lipid Metabolism and its Clinical and Immune Correlation in Lung Adenocarcinoma |
(Eng)
|
|
Zhang X., Li W., Liu T., Guo H., Sun Q., Li B.
|
| 卷 31, 编号 12 (2024) |
Identifying a Novel Eight-NK Cell-related Gene Signature for Ovarian Cancer Prognosis Prediction |
(Eng)
|
|
Li N., Yu K., Huang D., Zhou H., Zeng D.
|
| 卷 31, 编号 12 (2024) |
Identification of Key Genes in Angiogenesis of Breast and Prostate Cancers in the Context of Different Cell Types |
(Eng)
|
|
Jariani A., Kakroodi S., Arabfard M., Jamialahmadi T., Rahimi M., Sahebkar A.
|
| 卷 31, 编号 13 (2024) |
Meet the Editorial Board Member |
(Eng)
|
|
Beretta G.
|
| 卷 31, 编号 13 (2024) |
Beyond the Dusty Fog: Local Eye Drop Therapy and Potentially New Treatment Alternatives in Pseudoexfoliative Glaucoma |
(Eng)
|
|
Zeppieri M., Musa M.
|
| 卷 31, 编号 13 (2024) |
Early-Life Lead Exposure: Risks and Neurotoxic Consequences |
(Eng)
|
|
Bjørklund G., Tippairote T., Hangan T., Chirumbolo S., Peana M.
|
| 卷 31, 编号 13 (2024) |
CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy |
(Eng)
|
|
Mu Y., Guan X.
|
| 卷 31, 编号 14 (2024) |
Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects |
(Eng)
|
|
Abdelkhalek A., Attia M., Kamal M.
|
| 201 - 300 的 400 信息 |
<< < 1 2 3 4 > >>
|
